FANELLI, TIZIANA
 Distribuzione geografica
Continente #
NA - Nord America 2.806
EU - Europa 1.751
AS - Asia 853
SA - Sud America 87
Continente sconosciuto - Info sul continente non disponibili 72
AF - Africa 15
OC - Oceania 8
AN - Antartide 1
Totale 5.593
Nazione #
US - Stati Uniti d'America 2.770
RU - Federazione Russa 522
PL - Polonia 501
IT - Italia 252
SG - Singapore 252
CN - Cina 204
HK - Hong Kong 134
IE - Irlanda 109
VN - Vietnam 97
SE - Svezia 86
DE - Germania 76
BR - Brasile 62
FR - Francia 60
KR - Corea 54
FI - Finlandia 45
CH - Svizzera 33
JO - Giordania 32
IN - India 30
CA - Canada 24
GB - Regno Unito 24
ES - Italia 19
ID - Indonesia 10
AU - Australia 8
NL - Olanda 7
AR - Argentina 6
EC - Ecuador 6
IQ - Iraq 6
BD - Bangladesh 5
JP - Giappone 5
UA - Ucraina 5
BE - Belgio 4
CO - Colombia 4
EG - Egitto 4
PK - Pakistan 4
TR - Turchia 4
CI - Costa d'Avorio 3
MY - Malesia 3
VE - Venezuela 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
JM - Giamaica 2
KE - Kenya 2
MX - Messico 2
NP - Nepal 2
PY - Paraguay 2
UY - Uruguay 2
AQ - Antartide 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UZ - Uzbekistan 1
VG - Isole Vergini Britanniche 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
Totale 5.523
Città #
Santa Clara 514
Warsaw 500
Ashburn 365
Fairfield 297
Chandler 158
Singapore 153
Woodbridge 137
Seattle 128
Hong Kong 113
Cambridge 112
Dublin 109
Houston 103
Wilmington 89
Beijing 82
San Jose 78
Seoul 54
Ann Arbor 53
Altamura 48
Lawrence 42
Princeton 39
Dallas 38
Buffalo 37
Milan 36
Los Angeles 34
Bern 33
Florence 28
Hanoi 25
Bremen 24
The Dalles 24
Ho Chi Minh City 23
Boston 21
Munich 21
Rome 21
Council Bluffs 20
Lauterbourg 20
Shanghai 20
Clifton 18
Mumbai 18
Helsinki 17
Barcelona 16
New York 15
Paris 14
San Diego 11
Boardman 10
Dong Ket 10
Kent 10
Phoenix 10
Medford 9
Redondo Beach 9
Frankfurt am Main 8
London 8
Melbourne 8
Montreal 8
São Paulo 8
Turku 8
Norwalk 7
Orem 7
Chicago 6
Dearborn 6
Düsseldorf 6
Jakarta 6
Moscow 6
Toronto 6
Falls Church 5
Jacksonville 5
Tokyo 5
Brussels 4
Figino 4
Fuzhou 4
Haiphong 4
Hillsboro 4
Padua 4
Redwood City 4
Romainville 4
Turin 4
Waltham 4
Abidjan 3
Brescia 3
Brooklyn 3
Da Nang 3
Genoa 3
Guayaquil 3
Jinan 3
Johannesburg 3
Miano 3
Modena 3
Montevarchi 3
Naples 3
Pescara 3
Pune 3
Salvador 3
San Francisco 3
Shenzhen 3
Yubileyny 3
Amman 2
Ankara 2
Baghdad 2
Basra 2
Belo Horizonte 2
Bologna 2
Totale 3.985
Nome #
A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells 359
Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis 336
EZH2 mutational status predicts poor survival in myelofibrosis. 332
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients 257
Epidemiology and clinical relevance of mutations in post-polycythemia vera and post-essential thrombocythemia myelofibrosis. A study on 359 patients of the AGIMM group 251
Targeted deep sequencing in polycythemia vera and essential thrombocythemia 232
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients 231
First report of FIP1L1-PDGFR alpha-positive eosinophilic granulomatosis with polyangiitis 226
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis 224
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms 222
Clonal architecture of JAK2V617F mutated cells during treatment with ruxolitinib 212
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in Primary Myelofibrosis 212
Germline transmission of LNKE208Q variant in a family with myeloproliferative neoplasms 203
Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea 199
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 196
JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib 193
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients 193
Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patients 190
Infrequent occurrence of mutations in the PH domain of LNK in patients with JAK2 mutation-negative 'idiopathic' erythrocytosis. 183
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms. 172
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations. 167
Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia. 167
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients. 163
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells unveils the role of miR-155/JARID2 axis in abnormal megakaryopoiesis. 162
Prognotic Impact of Mutations in Systemic Mastocytosis 159
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations. 152
Totale 5.593
Categoria #
all - tutte 15.168
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.168


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022174 0 0 20 8 3 6 5 21 8 9 39 55
2022/2023671 52 144 41 52 45 94 72 44 70 1 19 37
2023/2024204 2 21 24 8 21 22 3 74 2 4 13 10
2024/20251.377 40 146 86 240 396 216 8 66 48 44 40 47
2025/20261.295 183 140 84 94 179 44 164 56 74 79 33 165
2026/2027124 36 25 63 0 0 0 0 0 0 0 0 0
Totale 5.593